Design and Evaluation of Sifuvirtide, a Novel HIV-1 Fusion Inhibitor
Open Access
- 1 April 2008
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 283 (17), 11126-11134
- https://doi.org/10.1074/jbc.m800200200
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Conserved Residue Lys574 in the Cavity of HIV-1 Gp41 Coiled-coil Domain Is Critical for Six-helix Bundle Stability and Virus EntryOnline Journal of Public Health Informatics, 2007
- Synergistic Inhibition of HIV-1 Envelope-Mediated Membrane Fusion by Inhibitors Targeting the N and C-Terminal Heptad Repeats of gp41Journal of Molecular Biology, 2006
- Emergence of Drug Resistance Is Associated with an Increased Risk of Death among Patients First Starting HAARTPLoS Medicine, 2006
- Progress in identifying peptides and small-molecule inhibitors targeted to gp41 of HIV-1Expert Opinion on Investigational Drugs, 2006
- Novel Therapies Based on Mechanisms of HIV-1 Cell EntryThe New England Journal of Medicine, 2003
- Design and Properties of NCCG-gp41, a Chimeric gp41 Molecule with Nanomolar HIV Fusion Inhibitory ActivityOnline Journal of Public Health Informatics, 2001
- Interactions between HIV-1 gp41 Core and Detergents and Their Implications for Membrane FusionOnline Journal of Public Health Informatics, 2000
- Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformationJournal of Molecular Biology, 2000
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999
- Determination of the helix and β form of proteins in aqueous solution by circular dichroismBiochemistry, 1974